Related Experiment Videos

Preservation of adenosine 5'-triphosphate and mitochondrial function during hypercalcemic reperfusion using verapamil

D R Jones1, A E Abbott, R C Hill

  • 1Department of Surgery, West Virginia University, Morgantown.

Chest
|February 1, 1995
PubMed

Insights

Verapamil cardioplegia preserves myocardial adenosine triphosphate (ATP) stores and mitochondrial function during hypercalcemic reperfusion. However, it does not improve postischemic ventricular dysfunction.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Biochemistry

Background:

  • Immediate hypercalcemic reperfusion can cause ventricular dysfunction and deplete myocardial energy stores.
  • Maintaining myocardial energy during reperfusion is critical for cardiac function recovery.

Purpose of the Study:

  • To assess the impact of verapamil cardioplegia on myocardial energy preservation, mitochondrial integrity, and ventricular function.
  • To investigate the effects of verapamil during immediate hypercalcemic reperfusion in a rat heart model.

Main Methods:

  • Rats received cardioplegia with potassium (control) or verapamil.
  • Groups underwent either normocalcemic or hypercalcemic reperfusion.
  • Adenosine triphosphate (ATP) levels, mitochondrial ultrastructure, and hemodynamic parameters were analyzed.

Main Results:

  • Verapamil cardioplegia maintained ATP stores above 100% of control levels.
  • No irreversible mitochondrial damage was observed with verapamil.
  • Verapamil treatment resulted in significantly depressed heart rate, aortic flow, and dP/dT.

Conclusions:

  • Verapamil cardioplegia protects myocardial ATP and mitochondrial function during immediate hypercalcemic reperfusion.
  • Verapamil does not enhance postischemic hemodynamic recovery in this model.
  • Further research may explore strategies to mitigate the negative hemodynamic effects of verapamil while retaining its protective benefits.

Related Concept Videos